Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Valderrama-Carmona

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisPablo Valderrama-Carmona, Federico Pratesi, Paule E H M'Bra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2026
Plasma extracellular vesicles from APOE3 Christchurch carriers display a protective phenotype in early stages of autosomal dominant Alzheimer's diseaseLina Pineda-Lopez, David Aguillon, Juan Villar-Vesga, et al.
Brain Pathology (Zurich, Switzerland)|September 21, 2022
Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotectionJulián Henao-Restrepo, Carolina López-Murillo, Pablo Valderrama-Carmona, et al.
The New England Journal of Medicine|June 20, 2024
<i>APOE3</i> Christchurch Heterozygosity and Autosomal Dominant Alzheimer's DiseaseYakeel T Quiroz, David Aguillon, Daniel C Aguirre-Acevedo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisPablo Valderrama-Carmona, Federico Pratesi, Paule E H M'Bra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2026
Plasma extracellular vesicles from APOE3 Christchurch carriers display a protective phenotype in early stages of autosomal dominant Alzheimer's diseaseLina Pineda-Lopez, David Aguillon, Juan Villar-Vesga, et al.
Brain Pathology (Zurich, Switzerland)|September 21, 2022
Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotectionJulián Henao-Restrepo, Carolina López-Murillo, Pablo Valderrama-Carmona, et al.
The New England Journal of Medicine|June 20, 2024
<i>APOE3</i> Christchurch Heterozygosity and Autosomal Dominant Alzheimer's DiseaseYakeel T Quiroz, David Aguillon, Daniel C Aguirre-Acevedo, et al.
Pageof 1